Arrowhead Pharmaceuticals
ARWR
#2239
Rank
ยฃ6.40 B
Marketcap
ยฃ45.73
Share price
-2.91%
Change (1 day)
184.50%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) - Total debt

Total debt on the balance sheet as of December 2025 : ยฃ0.22 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's total debt is ยฃ0.22 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Arrowhead Pharmaceuticals - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2025-09-30ยฃ0.27 B-28.62%
2024-09-30ยฃ0.38 B304.22%
2023-09-30ยฃ94.42 M28.8%
2022-09-30ยฃ73.31 M286.57%
2021-09-30ยฃ18.96 M15.89%
2020-09-30ยฃ16.36 M
2019-09-30N/A-100%
2018-09-30ยฃ1.78 M-5.71%
2017-09-30ยฃ1.89 M-10.13%
2016-09-30ยฃ2.1 M319.71%
2015-09-30ยฃ0.5 M-20.48%
2014-09-30ยฃ0.63 M-55.7%
2013-09-30ยฃ1.42 M-5.81%
2012-09-30ยฃ1.51 M288.94%
2011-09-30ยฃ0.38 M22.13%
2010-09-30ยฃ0.31 M-58.75%
2009-09-30ยฃ0.77 M-11.18%
2008-09-30ยฃ0.86 M
2002-09-30ยฃ0.4 M6.93%
2001-09-30ยฃ0.37 M-0.96%
2000-09-30ยฃ0.38 M11.73%
1999-09-30ยฃ0.34 M-45.49%
1998-09-30ยฃ0.62 M-0.91%
1997-09-30ยฃ0.63 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
ยฃ33.43 B 14,541.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
ยฃ0.53 B 134.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.32 B 44.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.95 B 318.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
ยฃ7.31 M-96.80%๐Ÿ‡บ๐Ÿ‡ธ USA